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S U M M A R Y
Background: The clinical signs of early-onset neonatal sepsis (EONS) are nonspeciﬁc and indistinguish-
able from those of noninfectious disorders. The early diagnosis of EONS is difﬁcult, but is essential to
improve outcomes. The aim of this study was to determine the diagnostic value of procalcitonin (PCT) at
birth and at 24 h of age in the prompt diagnosis of EONS.
Methods: The patient group consisted of neonates with a To¨llner score of 10 or a To¨llner score of 5–10
but with the presence of prolonged rupture of the membranes (>18 h) or chorioamnionitis or maternal
fever (n = 171). The control group (n = 89) comprised neonates admitted to the neonatal intensive care
unit for different disease entities. Procalcitonin levels at birth (ﬁrst) and at 24 h of age (second) were
measured for each neonate in both of the study groups.
Results: There was no difference between the two groups in terms of gender, birth weight, or gestational
age. The mean (min–max) ﬁrst PCT level was 0.48 (0.07–3.48) ng/ml in the controls and 0.51 (0.09–
28.6) ng/ml in patients. The mean (min–max) second PCT level was 1.72 (0.21–18.23) ng/ml in the
controls and 16.17 (0.17–100) ng/ml in patients. There was no statistically signiﬁcant difference in PCT
levels between the patient and control groups at birth. However, at 24 h of age, PCT levels were
signiﬁcantly higher in the patient group than in the control group (p < 0.001). Serum PCT levels in
controls at 24 h of age were slightly increased compared to levels at birth, but as a normal reaction. PCT
thresholds for the diagnosis of sepsis were 0.59 ng/ml at birth (sensitivity 48.7%, speciﬁcity 68.6%) and
5.38 ng/ml at 24 h of life (sensitivity 83.3%, speciﬁcity 88.6%).
Conclusions: In EONS, PCT measurements at birth may initially be normal; a serial PCT measurement at
24 h of age may be more helpful for an early diagnosis. During the ﬁrst 24 h of life PCT is a more sensitive
marker of infection than C-reactive protein. Further studies are needed to conﬁrm our ﬁndings.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Early-onset neonatal sepsis (EONS) is one of the leading causes
of neonatal morbidity and mortality, particularly in preterm
infants.1–3 Because the signs and symptoms of EONS are
nonspeciﬁc, a variety of noninfectious conditions can occur
together with neonatal infection or can make the diagnosis of
infection more difﬁcult. Therefore, neonates with risk factors for
infection, or for whom there is a clinical suspicion of infection, are
empirically treated with antibiotics. The initiation of antibiotic
treatment by physicians for all patients with a suspicion of sepsis,
since the risk of mortality is very high in non-treated or
inappropriately treated cases, leads to unnecessary antibiotics* Corresponding author. Tel.: +90 0 332 2237248; fax: +90 0 332 2236181.
E-mail address: aliannagur@yahoo.com (A. Annagu¨r).
1201-9712/$36.00 – see front matter  2011 International Society for Infectious Disea
doi:10.1016/j.ijid.2011.09.007being administered in the case of some non-infected newborns.
The early detection of the absence of infection would decrease the
number of children started on antibiotics, shorten the length of
hospital stay, and lessen the treatment costs and potential for the
emergence of resistant organisms. A deﬁnitive diagnosis of
neonatal sepsis can only be made with a positive blood culture,
but blood cultures are time-consuming. Furthermore, they may
yield false-positive results because of contamination. Also, blood
culture can remain negative despite generalized bacterial infec-
tion. To avoid the unnecessary treatment of uninfected patients, an
early, sensitive, and speciﬁc laboratory test would be helpful to
guide clinicians in deciding whether or not to start administering
antibiotics. C-reactive protein (CRP), white blood cell count,
absolute neutrophil count, and immature/total neutrophil ratio
are the most widely used tests in the diagnosis of sepsis. All provide
useful information, but none of them has been demonstrated to be
reliable in detecting all septic infants. This has led to the search forses. Published by Elsevier Ltd. All rights reserved.
Table 1
Characteristics of the study patients
Groupa Gestational age
(weeks), mean  SD
Birth weight (g),
mean  SD
Group 1 (n = 171) 33.8  4.3 2090  85
Group 2 (n = 89) 34.3  3.9 2356  86
p-Value p > 0.05 p > 0.05
SD, standard deviation.
a Group 1: patient/suspected sepsis group; group 2: control group.
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endothelin, and pro-atrial natriuretic peptide.2,4,5 Currently,
procalcitonin (PCT), interleukin (IL)-6, IL-8, and tumor necrosis
factor-alpha (TNF-a) are the most hopeful among these markers.6,7
PCT is the peptide prohormone of calcitonin and is produced
predominantly by monocytes and hepatocytes. The concentration
of PCT rises rapidly, within 3–4 h, in response to bacterial
endotoxin, and reaches its maximum concentration at approxi-
mately 18–24 h; it remains elevated for at least 24–48 h. The half-
life of PCT is approximately 24 h in peripheral blood.2,4,6 Serum
concentrations of PCT increase signiﬁcantly during systemic
bacterial and fungal infections, but not viral infections.8,9 In
contrast to the ﬁndings in infants and children, elevated PCT levels
have been observed even in uninfected and healthy newborns
within the ﬁrst 4 days of life.2,4,6–14 Most studies that have
investigated the kinetics of PCT during the ﬁrst few days of life
(predominantly term infants) have failed to show a high PCT
concentration at birth in septic newborns.6–8,14
The main purpose of this study was to determine the behavior
of serum PCT concentrations in infected and uninfected neonates
at birth and at 24 h of age, and to assess the value of this marker for
the diagnosis of EONS according to the time at which the sample is
obtained.
2. Materials and methods
This prospective study was conducted between June 2008 and
January 2011 at the Neonatal Intensive Care Unit of the Pediatric
Department, Selc¸uk University Faculty of Medicine, Konya, Turkey.
The diagnosis of EONS was made according to the presence of the
following parameters on clinical, laboratory, or culture screen: (1)
clinical signs consistent with infection based on the To¨llner
score;15 (2) CRP values of 1.0 mg/dl as determined by the rate
nephelometry method; (3) positive culture (blood, urine, cerebro-
spinal ﬂuid) or pneumonia (chest X-ray ﬁndings). The To¨llner
scoring system uses a range of clinical (change in skin color,
peripheral circulation impairment, hypotonia, bradycardia, apnea,
respiratory distress, hepatomegaly, abdominal distension) and
laboratory (leukocyte count, left shift, thrombocytopenia, meta-
bolic acidosis) parameters. Points are given for each parameter: 0,
1, 2, or 3; a higher number of points reﬂects a greater severity.
According to this scoring system, a score of 10 indicates clinical
sepsis, a score of 5 indicates no sepsis, and a score of 5–10
indicates possible sepsis. Gestational age, birth weight, history of
intrapartum maternal antibiotic administration, maternal fever
(38 8C), prolonged rupture of membranes (PROM) > 18 h, and
clinical chorioamnionitis were recorded. The study was approved
by the local ethics committee. Both verbal and written informed
consent were given by the parents.
Two groups of neonates were investigated. Group 1 – the
patient or suspected sepsis group – consisted of 190 neonates who
had been diagnosed with suspected clinical sepsis. Nineteen of
these neonates were excluded from the study because either the
mother or the newborn had already been given antibiotics. Thus,
171 neonates (preterm or term) were diagnosed with suspected
clinical sepsis based on a To¨llner score of 10 or a To¨llner score of
5–10 but with the presence of one or more of the following factors
associated with an increased risk of infection: PROM (18 h),
chorioamnionitis, and maternal fever during labor (38 8C).
Inclusion criteria were positive clinical signs of sepsis and/or a
history of factors associated with an increased risk of infection, and
parental informed consent. In addition, the criteria included
neonates with negative body ﬂuid cultures who met all of the
following criteria: clinical signs of sepsis and/or radiographic
ﬁndings consistent with pneumonia, a positive sepsis screen, and
certain historical and clinical factors associated with an increasedrisk of infection. Exclusion criteria were congenital malformations,
congenital infections associated with the TORCH complex, and
refusal of parental consent. Where there was a history of maternal
antibiotic administration, the neonate was excluded from the
study. In this group, antibiotics were commenced after the blood
specimens were collected.
Group 2 – the control group – comprised 89 neonates (preterm
or term) who had no clinical signs of sepsis during the ﬁrst week of
life, and who were seen to be healthy based on a To¨llner score of 5
or a To¨llner score of 5–10 but with no factors associated with an
increased risk of infection (PROM, chorioamnionitis, or maternal
fever during labor) and who had negative CRP results and blood
culture. Patients in this group did not receive antibiotic treatment.
Neonates who were discharged home before day 7 of life were
followed to ensure that they did not develop late-onset vertical
sepsis. This group consisted of preterm infants, neonates with birth
asphyxia, low birth weight, hypoglycemia, hypocalcemia, and fetal
distress, and those born to diabetic mothers.
Standard biochemical and hematological parameters, chest X-
rays, and samples for blood culture and CRP and PCT determina-
tions (collected by peripheral venous puncture) were obtained
before initiation of antibiotic therapy in infants suspected of sepsis
or at the moment of inclusion in the study in control infants. The
measurement of CRP levels was made using the latex immuno-
nephelometry method (BNA Analyzer, Behring-Werke AG, Mar-
burg, Germany). CRP levels of 5 mg/l were accepted as normal.
Serum PCT and CRP levels at birth (ﬁrst) and at 24 h of age (second)
were measured.
Blood for PCT determination was centrifuged within 30 min of
collection, and the serum was stored at 20 8C until analysis. PCT
was measured by a speciﬁc immunoluminometric assay requiring
20 ml of serum and 2 h to complete (Lumitest PCT, Brahm
Diagnostica GmbH, Berlin, Germany).
2.1. Statistical analysis
Statistical analyses were performed using the statistical
package SPSS v. 15.0 (SPSS Inc., Chicago, IL, USA). Since the data
were not normally distributed, comparisons of continuous
variables between groups were made using the Mann–Whitney
U-test. The reliability of serum PCT concentration for the diagnosis
of sepsis was calculated by receiver operating characteristics (ROC)
curves. The sensitivity, speciﬁcity, positive predictive value (PPV),
and negative predictive value (NPV) were calculated for PCT using
the cutoff values derived from the ROC analysis. Exact 95%
conﬁdence intervals (CI) were calculated for all the parameters.
Statistical signiﬁcance was assumed for p < 0.05.
3. Results
A total of 260 newborn infants, 171 with suspected sepsis
(group 1) and 89 in the control group (group 2), were included in
the study. Blood cultures were positive for 67 patients in group 1.
There were no blood culture-positive cases in group 2. Twenty of
the 171 suspected sepsis cases in group 1 died, but no deaths were
recorded during the ﬁrst week of life in the control group. Table 1
Table 2
Comparison of serum PCT and CRP levels between groups at birth and at 24 h of life
Serum marker Group 1a (n = 171) Group 2a (n = 89)
PCT at birth, mean
(min–max) ng/ml
0.51 (0.09–28.6) 0.48 (0.07–3.48)
PCT at 24 h, mean
(min–max) ng/ml
16.17 (0.17–100) 1.72 (0.21–18.23)
CRP at birth, mean
(min–max) mg/l
1.9 (0.0–68.2) 1.7 (0.0–32.4)
CRP at 24 h, mean
(min–max) mg/l
24.3 (0.0–104.6) 8.8 (0.0–63.8)
PCT, procalcitonin; CRP, C-reactive protein.
a Group 1: patient/suspected sepsis group; group 2: control group.
Figure 1. Receiver operating characteristics curve for procalcitonin (PCT) at birth for
the diagnosis of early-onset neonatal sepsis.
Figure 2. Receiver operating characteristics curve for procalcitonin (PCT) at 24 h of
life for the diagnosis of early-onset neonatal sepsis.
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signiﬁcant differences between the two groups with regard to
gestational age or birth weight (p  0.05).
The mean (min–max) ﬁrst PCT level (at birth) was 0.51 (0.09–
28.6) ng/ml in the patient group and 0.48 (0.07–3.48) ng/ml in
the controls. The mean (min–max) second PCT level (at 24 h)
was 16.17 (0.17–100) ng/ml in the patient group and 1.72 (0.21–
18.23) ng/ml in the controls. The mean (min–max) ﬁrst CRP level
was 1.9 (0.0–68.2) mg/l in the patient group and 1.7 (0.0–
32.4) mg/l in the controls. The mean (min–max) second CRP
level was 24.3 (0.0–104.6) mg/l in the patient group and 8.8
(0.0–63.8) mg/l in the controls (Table 2). When the serum PCT
and CRP levels were evaluated in the two groups, there was no
statistically signiﬁcant difference in PCT or CRP levels between
the patient and control groups at birth (p > 0.05). However, at
24 h of age, PCT and CRP levels were signiﬁcantly higher in the
patient group than in the control group (p < 0.001). Serum PCT
and CRP levels in controls at 24 h of age were slightly increased,
but within the normal range.
Figures 1 and 2 show the ROC curves for PCT at birth and at 24 h of
life, respectively, for the diagnosis of EONS. The cutoff levels of PCT
with optimum diagnostic efﬁciency derived from the ROC curves
were 0.59 ng/ml at birth (sensitivity 48.7%, speciﬁcity 68.6%) and
5.38 ng/ml at 24 h of life (sensitivity 83.3%, speciﬁcity 88.6%). The
cutoff levels of CRP with optimum diagnostic efﬁciency derived from
the ROC curves were >5 mg/l at birth (sensitivity 44.5%, speciﬁcity
59.4%) and >12 mg/l at 24 h of life (sensitivity 76.4%, speciﬁcity
78.9%) (Table 3). PCT showed the best sensitivity (83.3%) and the best
speciﬁcity (88.6%) at 24 h of life (standard cutoff).
4. Discussion
In this study we determined the behavior of serum PCT
concentrations in infected and uninfected neonates at birth and
at 24 h of age, and assessed the value of this marker for the diagnosis
of EONS according to the time at which the sample was obtained.
Neonatal sepsis is one of the leading causes of neonatal morbidity
and mortality. Early diagnosis and treatment are vital to improve the
outcome. PCT has been implicated as a sensitive and speciﬁc marker
of bacterial infection.6,10–12 However, there are some difﬁculties in
interpreting PCT values in the newborn period. The main problemTable 3
Sensitivity speciﬁcity, positive predictive value, and negative predictive value of PCT and CRP for the diagnosis of early-onset neonatal sepsis (cutoff values determined by
ROC analysis)
PCT at birth PCT at 24 h of life CRP at birth CRP at 24 h of life
Cutoff 0.59 ng/ml 5.38 ng/ml >5 mg/l >12 mg/l
Sensitivity, % (95% CI) 48.7 (39.45–57.89) 83.3 (76.28–90.08) 44.5 (33.59–56.77) 76.4 (68.18–85.28)
Speciﬁcity, % (95% CI) 68.6 (58.62–75.91) 88.6 (79.41–92.27) 59.4 (51.35–71.58) 78.9 (67.23–87.76)
PPV 48.71 83.33 45.62 79.75
NPV 68.57 88.57 64.25 81.62
PCT, procalcitonin; CRP, C-reactive protein; ROC, receiver operating characteristics; CI, conﬁdence interval; PPV, positive predictive value; NPV, negative predictive value.
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that occurs over the ﬁrst few days of life. Elevated PCT levels have
been observed even in uninfected and healthy newborns within the
ﬁrst 4 days of life.4,6–9,11–14 Further, non-infective perinatal events,
such as intracranial hemorrhage, perinatal asphyxia, respiratory
disorders, and fetal distress, may also cause an increase in circulating
PCT concentrations.1,4,6,10,13 As a result, age-speciﬁc cutoff values for
each evaluation point over the ﬁrst few days of life are needed to
improve the diagnostic accuracy of this marker of bacterial
infection.1,8,9,11–14,16 An increased PCT level appears to be a highly
speciﬁc and sensitive marker of EONS in the ﬁrst hours of life.
However, it should be remembered that a normal PCT level can be
seen in cases of severe sepsis.12,16 Thus, low or normal PCT levels
may complicate the diagnosis, particularly if clinical signs and
symptoms of sepsis are ‘silent’. Therefore, serial PCT determinations
will assist in the identiﬁcation of the infected neonate. Fendler and
Piotrowski17 reported that the diagnostic efﬁcacy was highest for
measurements made two or more hours since the onset of
symptoms of infection.
We compared the levels of PCT in the diagnosis of EONS. When
we analyzed the initial PCT level, there was no difference between
groups 1 and 2 (p > 0.05). However, at 24 h of age, PCT levels were
signiﬁcantly higher in group 1 than in group 2 (p < 0.001). We
found that the sensitivity, speciﬁcity, PPV, and NPV of PCT at birth
were 48.7%, 68.6%, 48.71%, and 68.57%, respectively, using a cutoff
value of 0.59 ng/ml. We also found that the sensitivity, speciﬁcity,
PPV, and NPV of PCT at 24 h of life were 88.3%, 88.6%, 83.33%, and
88.57%, respectively, using a cutoff value of 5.38 ng/ml. When the
groups were compared for the progression of PCT, there was a
slight increase in the control group between the ﬁrst (at birth) and
second (at 24 h of age) PCT levels. We suggest that this
phenomenon might be attributed to a physiological peak of serum
PCT concentration in healthy neonates during the immediate
postnatal period. Our results conﬁrm the ﬁndings of previous
reports in which the authors have referred to a relative PCT peak on
the ﬁrst day of life among uninfected infants.4,6,8,9,12–14 Although
the reasons for the increase in the PCT concentration seen during
the immediate postnatal period in infants who are apparently
healthy are not known, this increase appears to reﬂect a
physiological mechanism. In the patient group (group 1), the
difference between the ﬁrst and second PCT levels was highly
signiﬁcant (p < 0.001). The difference between the two measure-
ments was dramatic and above that of a physiological reaction, and
thus was accepted as highly meaningful.
There are several points that should be taken into consideration
in our study. First, the serum PCT concentration may be normal
immediately at birth in a septic newborn. In the case of EONS,
serum PCT levels would increase at 24 h of age. Therefore, in a
septic baby with a normal PCT level in the immediate postnatal
period, PCT determinations are repeated at 24 h of age. In our
study, 112 of the 171 newborns in group 1 had a low PCT
concentration at birth. Second, many clinical signs of infection are
seen in non-infectious conditions, such as transient tachypnea of
the newborn. Serial PCT measurements at birth and at 24 h of life
may be helpful in differentiating between EONS and these non-
infectious conditions. In our study it was found that serum levels of
PCT were signiﬁcantly increased at 24 h of age in septic newborns
when compared with the levels at birth, while levels of PCT
increased only slightly in the non-infectious conditions. Third,
increased PCT levels have been shown to be a highly sensitive
diagnostic parameter in the diagnosis of EONS when obtained
within the ﬁrst hour of life.11 In our study, 59 of the 171 newborns
in the patient group (group 1) had a PCT concentration higher than
0.59 ng/ml at birth. However, only 11 of the 89 newborns in the
control group (group 2) had a PCT concentration higher than 0.59
ng/ml at birth. In septic neonates who had PCT levels higher than0.59 ng/ml at birth, it was observed that serum PCT levels at 24 h of
age had increased further, while in control newborns who had PCT
levels higher than 0.59 ng/ml in the ﬁrst hour of life, there was no
increase at 24 h of age. Fourth, PCT levels are valuable in following
the effectiveness of treatment and in determining the prognosis of
the disease and mortality.10,18,19 In our study, 20 of the 171
neonates in the patient group died during the ﬁrst week of life; no
death was recorded during the ﬁrst week of life in the control
group. Fifth, because of the physiological increase in PCT levels
over the ﬁrst few days of life and hourly changes in normal PCT
values, its applicability as a marker of bacterial infection requires
speciﬁc cutoff values for each evaluation point over the ﬁrst 4 days
of life.4,8,13,16
In the study of Chiesa et al.,16 birth weight, length of gestation,
and other factors inherently due to either prematurity or low birth
weight did not signiﬁcantly affect normal PCT values, therefore
demonstrating that the level of development has no effect on the
PCT response. In our study, there were no signiﬁcant differences
between the two groups with regard to gestational age, gender, or
birth weight.
Previous studies have demonstrated the important role of CRP,
IL-6, IL-8, and PCT in the diagnosis of EONS. Bender et al.20 showed
a high speciﬁcity and sensitivity of combinations of infection
markers, such as IL-6 in conjunction with PCT. Also Kordek et al.21
demonstrated that PCT combined with CRP values is a useful way
to evaluate EONS at the time of suspicion of infection. However,
PCT appears to be the most helpful indicator marker for the early
diagnosis of EONS.2,4,6,10–13,16,17,22 In a recent meta-analysis, Yu et
al.23 concluded that the PCT test was more accurate than the CRP
test for the diagnosis of neonatal sepsis.
We found that the sensitivity, speciﬁcity, PPV, and NPV of CRP at
birth were 44.5%, 59.4%, 45.62%, and 64.25%, respectively, using a
cutoff value of 5 mg/l. We also found that the sensitivity,
speciﬁcity, PPV, and NPV of CRP at 24 h of life were 76.4%,
78.9%, 79.75%, and 81.62%, respectively, using a cutoff value of
12 mg/l. These ﬁndings suggest that PCT might be a more sensitive
diagnostic parameter within the ﬁrst 24 h of life than CRP.
In conclusion, the serum PCT measurement may be useful for
the diagnosis of EONS. Because the dynamics of PCT and CRP are
time-dependent, serial PCT and CRP measurements at birth and at
24 h of age may be more helpful for the diagnosis of EONS. We
think that an increased second serum PCT measurement at 24 h of
age would be more indicative of EONS than an increased ﬁrst PCT
measurement at birth. We suggest that if a neonate has minimal or
no symptoms and the serum PCT level has not signiﬁcantly
increased after 24 h of life, the baby may be discharged earlier than
other babies. Also, we consider that during the ﬁrst 24 h of life PCT
is a more sensitive marker of infection than CRP. Further studies
are needed to conﬁrm our ﬁndings.
Conﬂict of interest: No conﬂict of interest to declare.
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